)
Edge20 Feb 2026
Dollar General: The Rural Retailer Playbook
How Dollar General built a small-box empire across rural America, scaling value and convenience into one of retail's most durable business models.
Puma Biotechnology
Puma Biotechnology (PBYI) investor relations material
Puma Biotechnology TD Cowen 46th Annual Health Care Conference summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.TD Cowen 46th Annual Health Care Conference summary2 Mar, 2026
Commercial performance and financial outlook
NERLYNX net revenue reached $59.9 million in Q4 2025, up from $54.4 million in Q4 2024 and $51.9 million in Q3 2025.
3,298 bottles sold in Q4 2025, an increase from 2,964 in Q4 2024 and 2,949 in Q3 2025.
75% of new U.S. patients started NERLYNX at a reduced dose in Q4 2025 to improve tolerability.
2026 full-year revenue guidance for NERLYNX is $194–$198 million, with total revenue projected at $214–$221 million and net income of $10–$13 million.
Q1 2026 revenue expected at $38–$42 million, with a small net loss of $8–$10 million.
Pipeline and clinical development updates
Alisertib is in two phase II trials: ALISCA-Breast1 (HR-positive, HER2-negative metastatic breast cancer) and ALISCA-Lung1 (small cell lung cancer).
Interim data from both ALISCA-Breast1 and ALISCA-Lung1 expected in 2026, with full data from ALISCA-Breast1 anticipated in Q4 2026.
Ongoing study of neratinib with T-DXd (Enhertu) shows promising tumor shrinkage in multiple cancer types, including those not typically HER2-driven.
Alisertib has demonstrated clinical activity in HR-positive, HER2-negative breast, triple-negative breast, and small cell lung cancer.
Biomarker-driven strategies are being pursued for potential accelerated approval pathways.
Regulatory, intellectual property, and strategic considerations
NERLYNX holds U.S. commercial rights and is partnered internationally with multiple distributors.
Key patents for NERLYNX extend to 2031, and for alisertib to 2034, with ongoing efforts to extend IP life.
Patent litigation with AstraZeneca resulted in an initial $107.5 million award, later overturned; appeal is ongoing.
FDA approval for new indications will likely require randomized trials, especially in ER-positive breast cancer.
Financial discipline is prioritized, with a focus on maintaining profitability and minimizing the need for new equity raises.
Detail Alisertib single-arm approval path
Impact of dose escalation on NERLYNX growth?
Post-debt, what's the R&D investment strategy?
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next Puma Biotechnology earnings date
Q1 20267 May, 2026
Puma Biotechnology
Next Puma Biotechnology earnings date
Q1 20267 May, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Puma Biotechnology Inc. is a biopharmaceutical company focused on the development and commercialization of therapies for the treatment of cancer. The company specializes in targeted oncology, developing drugs that aim to improve outcomes for patients with specific types of cancer by addressing unmet medical needs. It collaborates with healthcare professionals, researchers, and regulatory bodies to advance its clinical and commercial objectives. The company is headquartered in Los Angeles, California, and its shares are listed on the NASDAQ.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage